These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35269303)

  • 1. Efficacy of Gold Nanoparticles against Drug-Resistant Nosocomial Fungal Pathogens and Their Extracellular Enzymes: Resistance Profiling towards Established Antifungal Agents.
    Almansob A; Bahkali AH; Ameen F
    Nanomaterials (Basel); 2022 Feb; 12(5):. PubMed ID: 35269303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective treatment of resistant opportunistic fungi associated with immuno-compromised individuals using silver biosynthesized nanoparticles.
    Almansob A; Bahkali AH; Albarrag A; Alshomrani M; Binjomah A; Hailan WA; Ameen F
    Appl Nanosci; 2022; 12(12):3871-3882. PubMed ID: 35909460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial efficacy of drug blended biosynthesized colloidal gold nanoparticles from Justicia glauca against oral pathogens: A nanoantibiotic approach.
    Emmanuel R; Saravanan M; Ovais M; Padmavathy S; Shinwari ZK; Prakash P
    Microb Pathog; 2017 Dec; 113():295-302. PubMed ID: 29101061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of posaconazole and comparators versus opportunistic filamentous fungal pathogens globally collected during 8 years.
    Pfaller MA; Carvalhaes CG; Messer SA; Rhomberg PR; Castanheira M
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115473. PubMed ID: 34352433
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Pfaller MA; Huband MD; Flamm RK; Bien PA; Castanheira M
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unsaturated fatty acid perturbation combats emerging triazole antifungal resistance in the human fungal pathogen
    Gutierrez-Perez C; Puerner C; Jones JT; Vellanki S; Vesely EM; Xatse MA; Viera AFC; Olsen CP; Attiku KO; Cardinale S; Kwasny SM; G-Dayanandan N; Opperman TJ; Cramer RA
    mBio; 2024 Jul; 15(7):e0116624. PubMed ID: 38934618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections.
    Moen MD; Lyseng-Williamson KA; Scott LJ
    Drugs; 2009; 69(3):361-92. PubMed ID: 19275278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antifungal activity of a novel lipopeptide antifungal agent, FK463, against various fungal pathogens.
    Uchida K; Nishiyama Y; Yokota N; Yamaguchi H
    J Antibiot (Tokyo); 2000 Oct; 53(10):1175-81. PubMed ID: 11132964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vitro Effects of Farnesol Alone and in Combination with Antifungal Drugs Against Aspergillus Clinical Isolates.
    Onder S; Oz Y
    Med Mycol J; 2021; 62(1):5-10. PubMed ID: 33642525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting the Anticancer Activity of Aspergillus flavus "endophyte of Jojoba" Taxol via Conjugation with Gold Nanoparticles Mediated by γ-Irradiation.
    Abdel-Fatah SS; El-Sherbiny GM; Khalaf M; Baz AFE; El-Sayed ASA; El-Batal AI
    Appl Biochem Biotechnol; 2022 Aug; 194(8):3558-3581. PubMed ID: 35438406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics.
    Mohsin SA; Shaukat S; Nawaz M; Ur-Rehman T; Irshad N; Majid M; Hassan SSU; Bungau S; Fatima H
    Front Pharmacol; 2022; 13():1067697. PubMed ID: 36506532
    [No Abstract]   [Full Text] [Related]  

  • 13. Fungal-specific Cyp51 inhibitor VT-1598 demonstrates in vitro activity against Candida and Cryptococcus species, endemic fungi, including Coccidioides species, Aspergillus species and Rhizopus arrhizus.
    Wiederhold NP; Patterson HP; Tran BH; Yates CM; Schotzinger RJ; Garvey EP
    J Antimicrob Chemother; 2018 Feb; 73(2):404-408. PubMed ID: 29190379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi.
    Espinel-Ingroff A
    J Clin Microbiol; 2001 Mar; 39(3):954-8. PubMed ID: 11230410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro polymyxin activity against clinical multidrug-resistant fungi.
    Yousfi H; Ranque S; Rolain JM; Bittar F
    Antimicrob Resist Infect Control; 2019; 8():66. PubMed ID: 31044071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal Resistance Profile of Fungal Isolates from Fungal Rhinosinusitis Patients: A Study from Tertiary Care Hospital.
    Sriramajayam L; Kaur R; Dhakad MS; Gulati A
    J Lab Physicians; 2023 Dec; 15(4):488-492. PubMed ID: 37780889
    [No Abstract]   [Full Text] [Related]  

  • 17. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
    Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
    Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial efficacy of Mentha piperata-derived biogenic zinc oxide nanoparticles against UTI-resistant pathogens.
    Ahmad N; Ali S; Abbas M; Fazal H; Saqib S; Ali A; Ullah Z; Zaman S; Sawati L; Zada A; Sohail
    Sci Rep; 2023 Sep; 13(1):14972. PubMed ID: 37696980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Six Antifungal Susceptibilities of 11
    Lee H; Choi SH; Oh J; Koo J; Lee HJ; Cho SI; Shin JH; Lee HK; Kim SY; Lee CH; Kim YR; Sohn YH; Kim WJ; Ryu SW; Sung GH; Kim J
    Microbiol Spectr; 2022 Apr; 10(2):e0125321. PubMed ID: 35384691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal susceptibility profile of invasive
    Memon S; Farooqi J; Zafar U; Naqvi SF; Zafar A; Jabeen K
    J Med Microbiol; 2021 Dec; 70(12):. PubMed ID: 34878377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.